Search Within

Zachary Michael Sethna

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
  3. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (12)
  2. GSK Faculty (12)
  3. Human Oncology and Pathogenesis Program (12)
  4. Sloan Kettering Institute Postdocs (12)
  5. Surgery (12)
  6. Department of Pathology and Laboratory Medicine (10)

More Groups

People
  1. Vinod Balachandran (12)
  2. Luis Rojas Exposito (10)
  3. Benjamin Greenbaum (8)
  4. Kevin Soares (8)
  5. Pablo Guasp Baratech (7)
  6. Abderezak Zebboudj (6)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (1)
  4. 2022 (4)
  5. 2021 (3)
  6. 2020 (1)

More Years

Publications
  1. Nature (5)
  2. Cancer Research (3)
  3. Journal for ImmunoTherapy of Cancer (2)
  4. Cancer Cell (1)
  5. Journal of Clinical Oncology (1)
Publishers
  1. Nature Publishing Group (5)
  2. American Association for Cancer Research (3)
  3. Biomed Central Ltd (2)
  4. American Society of Clinical Oncology (1)
  5. Cell Press (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • RNA vaccines for cancer: Principles to practice
    Review

    Guasp, P.; Reiche, C.; Sethna, Z.; Balachandran, V. P.
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Gut dysbiosis suppresses anti-tumor ILC2S in pancreatic cancer
    Meeting Abstract

    Zebboudj, A.; Amisaki, M.; Guasp, P.; Rojas, L.; Sethna, Z.; Theresa, W.; Chandra, A.; Yu, R.; Odgerel, Z.; Soares, K.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Rojas, L. A.; Łuksza, M.; Sethna, Z. M.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long term survivors of pancreatic cancer
    Meeting Abstract

    Luksza, M.; Sethna, Z.; Rojas, L.; Soares, K.; Elhanati, Y.; Lihm, J.; Hoyos, D.; Kappagantula, R.; Moore, A. M.; Patterson, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save